On October 28-29, 2013, Q1 Productions hosted a conference on Clinical Data Management Innovation. On October 29, 2013, FLH's Brian J. Malkin and Julie Kurzrok presented an "Update on FDA's Draft Guidance for Electronic Source Data in Clinical Investigations". The two-day Conference featured a look at innovative strategies and technologies affecting forward-thinking companies involved in clinical studies and clinical data management. The Conference included topics of interest to clinical data managers ("CDMs") as well as individuals who supervise or support CDMs to better understand the evaluation and selection of new technologies to meet FDA's and other regulatory requirements for collecting and managing clinical data. The focus was on information relevant to industry executives and included discussions how to select vendors for running clinical trials and managing clinical data.
First, Colleen Cox, Senior Manager, Data Management, Infinity Pharmaceuticals, provided an overview of the function of a CDM in a pharmaceutical/biotech company and how CDMs ensure that clinical data is accurate, logical, consistent, and complete. Dan Ringenbach, Sr. Enterprise Architect, AstraZeneca, Research and Development Information, then provided an overview of existing and future technologies that may be used in clinical data management, including "the Cloud", mobile platforms, as well as ways to manage the increasing trend towards electronic clinical data information. With the goal of "seamless integration", various technologies may be used to create data dashboards that have the potential to deliver increased data quality and reliability. With the increased information, organizations such as the Clinical Data Interchange Standards Consortium ("CDISC") have emerged to help develop standards for the acquisition, submission, and exchange of clinical research data, as was explained by Shannon Labout, CDISC Expert and Authorized Instructor. FDA wants data that conforms to CDISC standards, Labout said, which may be required in the near future.
Jason Raines, Head, Global Data Operations, Alcon Laboratories, Inc., provided a comprehensive look at how to select, negotiate, and contract electronic data capture ("EDC") vendors that are frequently utilized in clinical trials. Once an EDC provider is selected, it is important to develop an effective implementation and roll-out plan to provide a structured approach for success. Raines suggested testing an EDC vendor with a pilot before committing resources to one vendor and to develop metrics to demonstrate value from the vendor's program going forward. Hand-in-hand with selecting an EDC, Anne C. Hansen, Senior Study Data Manager, Genetech, Inc. and Roche Ltd., explained how the EDC vendors can work with contract research organizations ("CROs").